Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-012224

Director acquired 3,739 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krogulski Kenneth Director 2023-08-16 Other acquisition 10b5-1 +325 $1.67 $543 210,280 D
Krogulski Kenneth Director 2023-08-17 Other acquisition 10b5-1 +325 $1.73 $562 210,605 D
Krogulski Kenneth Director 2023-08-18 Other acquisition 10b5-1 +325 $1.73 $562 210,930 D
Krogulski Kenneth Director 2023-08-21 Other acquisition 10b5-1 +325 $1.71 $556 211,255 D
Krogulski Kenneth Director 2023-08-22 Other acquisition 10b5-1 +325 $1.75 $569 211,580 D
Krogulski Kenneth Director 2023-08-23 Other acquisition 10b5-1 +325 $1.73 $562 211,905 D
Krogulski Kenneth Director 2023-08-24 Other acquisition 10b5-1 +134 $1.69 $226 212,039 D
Krogulski Kenneth Director 2023-08-25 Other acquisition 10b5-1 +325 $1.73 $562 212,364 D
Krogulski Kenneth Director 2023-08-28 Other acquisition 10b5-1 +325 $1.74 $566 212,689 D
Krogulski Kenneth Director 2023-08-29 Other acquisition 10b5-1 +355 $1.70 $604 213,044 D
Krogulski Kenneth Director 2023-08-30 Other acquisition 10b5-1 +325 $1.71 $556 213,369 D
Krogulski Kenneth Director 2023-08-31 Other acquisition 10b5-1 +325 $1.70 $553 213,694 D
Loading xslF345X05/marketforms-62561.xml…